Oxidative stress in chronic hepatitis C: not just a feature of late stage disease

被引:151
作者
Jain, SK
Pemberton, PW
Smith, A
McMahon, RFT
Burrows, PC
Aboutwerat, A
Warnes, TW
机构
[1] Manchester Royal Infirm, Dept Gastroenterol, Liver Unit, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, Dept Pathol Sci, Manchester, Lancs, England
关键词
oxidant stress; 8-isoprostane; hepatitis C; antioxidant; cirrhosis;
D O I
10.1016/S0168-8278(02)00060-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Chronic hepatitis C infection is a major world-wide problem, frequently progressing to cirrhosis, liver failure or hepatoma. The pathological mechanisms of disease progression are unclear but oxidant stress may play a role. Methods: Markers of lipid peroxidation, antioxidant status, hepatic fibrogenesis and liver function were measured in blood or urine from 42 chronic hepatitis C patients. Fibrosis was graded histologically in a subgroup of 33 patients. Results: The lipid peroxidation marker 8-isoprostane and the ratio of oxidized to reduced glutathione were significantly elevated (P < 0.001, P = 0.006). The antioxidants glutathione, selenium and vitamins A, C and E were significantly decreased (all P < 0.001) compared to age and sex matched controls. Abnormal values were more marked in cirrhotics, but significant changes were also observed in the non-cirrhotic group. The fibrosis score correlated positively with urinary 8-isoprostane and type III procollagen peptide and negatively with vitamin A. Conclusions: Oxidant stress, as reflected in blood and urine by a wide range of pro- and antioxidant markers, is a significant feature of hepatitis C infection. Although more severe in the cirrhotic group, there was clear evidence of oxidant stress in non-cirrhotic patients. Antioxidant therapy may therefore have a role in slowing disease progression to cirrhosis. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:805 / 811
页数:7
相关论文
共 50 条
[1]  
Akerboom T P, 1981, Methods Enzymol, V77, P373
[2]  
AWAD JA, 1995, HEPATOLOGY, V22, P962, DOI 10.1016/0270-9139(95)90321-6
[3]  
BABBS C, 1988, LANCET, V1, P1021
[4]   Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype [J].
Barbaro, G ;
Di Lorenzo, G ;
Ribersani, M ;
Soldini, M ;
Giancaspro, G ;
Bellomo, G ;
Belloni, G ;
Grisorio, B ;
Barbarini, G .
JOURNAL OF HEPATOLOGY, 1999, 30 (05) :774-782
[5]   Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy [J].
Barden, A ;
Beilin, LJ ;
Ritchie, J ;
Croft, KD ;
Walters, BN ;
Michael, CA .
CLINICAL SCIENCE, 1996, 91 (06) :711-718
[6]  
Baroni GS, 1998, HEPATOLOGY, V27, P720
[7]   N-ACETYL CYSTEINE ENHANCES THE RESPONSE TO INTERFERON-ALPHA IN CHRONIC HEPATITIS-C - A PILOT-STUDY [J].
BELOQUI, O ;
PRIETO, J ;
SUAREZ, M ;
GIL, B ;
QIAN, CH ;
GARCIA, N ;
CIVEIRA, MP .
JOURNAL OF INTERFERON RESEARCH, 1993, 13 (04) :279-282
[8]   Glutathione kinetics in normal man and in patients with liver cirrhosis [J].
Bianchi, G ;
Bugianesi, E ;
Ronchi, M ;
Fabbri, A ;
Zoli, M ;
Marchesini, G .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :606-613
[9]   THE RENAL CLEARANCE OF ENDOGENOUS CREATININE IN MAN [J].
BROD, J ;
SIROTA, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (05) :645-654
[10]   Plasma selenium in patients with cirrhosis [J].
Burk, RE ;
Early, DS ;
Hill, KE ;
Palmer, IS ;
Boeglin, ME .
HEPATOLOGY, 1998, 27 (03) :794-798